Humana's (HUM) has seen a significant downward shift in recent times due to a plunge in their Medicare Star ratings which has raised a red flag for long-term investors. As a result, their stock has reached multi-year lows.
Barclays, Truist, and RBC Capital have all reduced their price targets for Humana in the light of these developments. Amidst the stock's slump and investors' panic,
Bernstein has upgraded the stock citing an attractive entry point. This can possibly indicate a deep value stock to consider. Contributing to its financial maneuvers, the
Humana Foundation has donated an additional $500,000 for disaster recovery in Florida proceeding
Hurricane Milton. Keybanc has initiated Humana's coverage at 'Sector Perform'. On the other hand, notable securities fraud law firm,
Glancy Prongay & Murray LLP has commenced an investigation on Humana on behalf of investors. Despite the tumultuous period, Humana has been found among hedge funds' popular choices in health insurance stocks.
Humana HUM News Analytics from Wed, 31 Jul 2024 07:00:00 GMT to Sat, 12 Oct 2024 12:01:09 GMT -
Rating -7
- Innovation -5
- Information 6
- Rumor -5
